首页|TNF-α和IL-1β通过MAPK通路上调人支气管平滑肌细胞的缓激肽受体和内皮素受体

TNF-α和IL-1β通过MAPK通路上调人支气管平滑肌细胞的缓激肽受体和内皮素受体

扫码查看
目的 支气管平滑肌对气道收缩剂的高反应性是哮喘的主要病理表现,但这种现象背后的分子机制尚未明确.肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)的释放对气道高反应性的发生起重要作用.研究旨在考察促炎性细胞因子 TNF-α和IL-1β对缓激肽、内皮素-1和血栓素A2的G蛋白偶联受体(GPCR)在人支气管平滑肌细胞(HBSMCs)中mRNA水平的影响.方法 将HBSMCs与炎性细胞因子 TNF-α,IL-1β,IL-6,IL-13以及MAPK信号通路抑制剂共同培养后,检测缓激肽受体B1和B2、内皮素B受体、血栓素A2受体和β2肾上腺素受体mRNA水平的变化.结果 TNF-α增加了HBSMCs中缓激肽B1和B2受体的mRNA水平,IL-1β增加了 HBSMCs中的内皮素B受体的 mRNA水平.P38 MAPK 抑制剂 SB203580和 JNK 抑制剂SP600125降低了TNF-α上调的缓激肽受体mRNA水平,MEK1/2抑制剂U0126和IκB激酶抑制剂TPCA-1消除了由IL-1β引起的内皮素B受体的mRNA水平增加.结论 TNF-α通过p38 MAPK和JNK信号通路在转录水平上调缓激肽B1和B2受体,IL-1β通过MEK1/2和下游NF-κB通路在转录水平上调HBSMCs中内皮素B受体.
TNF-α and IL-1βupregulate bradykinin receptors and endothelin receptor in human bronchial smooth muscle cells via MAPK signaling pathways
Objective The molecular mechanisms behind airway-hyperresponsiveness to bronchoconstrictor are not fully understood. Release of tumor necrosis factor-alpha(TNF-α)and interleukin-1beta(IL-1β)during the inflammatory process is believed to play an important role in airway hyperresponsiveness.In the present study,the effects of pro-inflammatory cytokines TNF-αand IL-1β on the G-protein coupled receptors(GPCRs)mRNA for bradykinin,endothelin-1 and thromboxane A2in human airway smooth muscle cells(HBSMCs)were investigated.Methods Human bronchial smooth muscle cells(HBSMCs)were treated with TNF-α, IL-1β,IL-6,IL-13 and MAPK signaling pathway inhibitors,then bradykinin receptor B1 and B2,endothelin type B receptor,throm-boxane A2receptor and β2-adrenoceptor mRNA was investigated.Results Bradykinin B1 and B2 receptor mRNA was increased by TNF-αand endothelin type B receptor mRNA was increased by IL-1βin HBSMCs.P38 MAPK inhibitor SB203580 and JNK inhibi-tor SP600125 attenuated the TNF-αenhanced bradykinin receptors mRNA and MEK1/2 inhibitor U0126 and IκB kinase inhibitor TPCA-1 abrogated the IL-1βenhanced endothelin type B receptor mRNA.Conclusion TNF-αtranscriptionally upregulates bradyki-nin B1 and B2 receptors via p38 MAPK and JNK signaling pathway and IL-1βtranscriptionally upregulates the endothelin receptor type B via MEK1/2 and the downstream NF-κB pathway in HBSMCs.

TNF-αIL-1βhuman bronchial smooth muscle cellbradykinin receptorendothelin B receptorMAPK

蔡艳、杨旭东、雷莹

展开 >

西安交通大学第二附属医院药学部,西安 710004

西安交通大学医学部生物化学与分子生物学系,西安 710061

深圳华大生命科学研究院,深圳 518083

TNF-α IL-1β 人支气管平滑肌细胞 缓激肽受体 内皮素B受体 MAPK

国家自然科学基金国家自然科学基金西安交通大学第二附属医院科研基金

8120000181603175和81370123YJQN201309

2018

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2018.33(3)
  • 9
  • 2